GlassScriptPhysician profile
Sailesh Shah
NPI 1437191244
$23,115.96
in general payments reported to CMS, 2019-2025
47 companies · $5,392 in 2025
The $5,392 reported for 2025 was more than what 89% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,198 · 2020: $1,900 · 2021: $1,670 · 2022: $4,701 · 2023: $3,001 · 2024: $4,254 · 2025: $5,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $39.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,607.68 |
| Education | $39.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $5,813.13 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $5,070.30 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Genzyme Corporation | $3,676.69 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,472.26 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Philips North America LLC | $699.13 | 2019-2025 | Image Management Subscription, (Ae4) Secretion Management, Vest Therapy Und |
| Takeda Pharmaceuticals U.S.A., INC. | $637.29 | 2020-2025 | Glassia, Hyqvia, Cuvitru |
| Regeneron Healthcare Solutions, INC. | $517.50 | 2021-2025 | Dupixent |
| Verona Pharma, INC. | $502.92 | 2025 | Ohtuvayre |
| United Therapeutics Corporation | $432.75 | 2019-2025 | Tyvaso, Orenitram, Remodulin |
| Insmed, INC. | $432.41 | 2019-2025 | Arikayce, Brinsupri |
| Amgen INC. | $409.89 | 2021-2025 | Tezspire |
| Inspire Medical Systems, INC. | $390.34 | 2025 | Inspire |
| Jazz Pharmaceuticals INC. | $384.20 | 2019-2025 | |
| Harmony Biosciences LLC | $369.65 | 2020-2025 | Wakix |
| Actelion Pharmaceuticals US, INC. | $365.43 | 2022-2024 | Uptravi, Opsumit |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $229.65 | 2021-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $128.53 | 2021-2025 | |
| Pfizer INC. | $119.80 | 2019-2024 | |
| 3b Medical, INC. | $118.00 | 2023 | Luna |
| Genentech USA, INC. | $115.36 | 2019 | |
| Mallinckrodt Hospital Products INC. | $112.10 | 2021-2025 | Acthar |
| Intuitive Surgical, INC. | $97.56 | 2024 | |
| Janssen Pharmaceuticals, INC | $93.37 | 2022-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $78.89 | 2019-2025 | Winrevair |
| Pulmonx Corporation | $74.19 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Paratek Pharmaceuticals, INC. | $73.73 | 2023-2024 | Nuzyra |
| Lilly USA, LLC | $64.36 | 2025 | Zepbound |
| Itamar Medical INC | $62.01 | 2025 | Watchpatone |
| Baxter Healthcare | $61.11 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Shionogi INC | $57.10 | 2021-2022 | |
| Abbott Laboratories | $48.96 | 2021-2022 | |
| Grifols USA, LLC | $47.70 | 2023-2024 | Prolastin-C Liquid |
| Teva Pharmaceuticals USA, INC. | $38.75 | 2022 | |
| Inogen, INC. | $35.26 | 2024-2025 | |
| Sanofi US Services INC. | $30.61 | 2024 | |
| Covis Pharma Gmbh | $28.89 | 2022 | |
| Circassia INC. | $28.60 | 2019-2020 | |
| Gilead Sciences, INC. | $28.58 | 2024 | |
| Shire North American Group INC | $21.60 | 2019 | |
| Portola Pharmaceuticals, LLC | $20.50 | 2020 | |
| Csl Behring | $20.46 | 2019 | |
| Scpharmaceuticals INC. | $20.16 | 2025 | |
| Fisher & Paykel Healthcare INC | $19.99 | 2023 | Fisher & Paykel Healthcare |
| Mylan Specialty L.P. | $19.55 | 2023 | Yupelri |
| Optinose US, INC. | $16.84 | 2025 | |
| Phadia US INC. | $15.42 | 2024 | Immunocap |
| Inari Medical, INC. | $14.44 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sailesh Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.